Category: On CallSyndicate content

Report: Docs excuse iffy procedures when money is on the line | On Call

April 16, 2014 by Arezu Sarvestani

Medical societies asked to name potentially needless treatments tend to leave out procedures that put money in their pockets, according to a Kaiser Health News/Chicago Tribune report. On Call

MASSDEVICE ON CALL — A survey of U.S. medical groups found that few are willing to criticize uncertain treatments that put money in their members' pockets.

When asked about potentially needless procedures, most doc groups cited treatments that were rarely used in practice or named procedures belonging to specialties other than their own. Most stood behind treatments that are considered uncertain yet lucrative, according to a joint report by Kaiser Health News and the Chicago Tribune.

Is there an Obamacare silver lining for medtech? | On Call

April 15, 2014 by Arezu Sarvestani

Wall Street analyst writer Sean Williams speculates that the Affordable Care Act, complete with the medical device tax, may actually help spur innovation rather than hamper it. On Call

MASSDEVICE ON CALL — Wall Street analyst and Motley Fool writer Sean Williams sees an Obamacare upside for the medical device industry, despite the doom and gloom forecast usually spurred by talk of the medical device tax.

Yet another warning letter for Hospira | On Call

April 14, 2014 by Arezu Sarvestani

FDA regulators issue a formal warning asking Hospira to provide more information on steps taken to address quality control issues highlighted in previous notices. On Call

MASSDEVICE ON CALL — Drug pump maker Hospira (NYSE:HSP) was the subject of another FDA warning letter posted this month, in which FDA officials asked for more information about steps taken to address quality control violations.

Consumers group aims to take down J&J and CEO Gorsky | On Call

April 11, 2014 by Arezu Sarvestani

The Corporate Action Network is taking aim at Johnson & Johnson and CEO Alex Gorsky, asking for tips about wrongdoing at the company. On Call

MASSDEVICE ON CALL — The Corporate Action Network is looking for tips to help take down healthcare giant Johnson & Johnson (NYSE:JNJ) and its CEO, Alex Gorsky.

Hypertension: Docs turn on renal denervation | On Call

April 10, 2014 by Arezu Sarvestani

U.S. and E.U. cardiologists call for a hard check on global sales of renal denervation technology in the wake of Medtronic's disappointing SYMPLICITY HTN-3 study. On Call

MASSDEVICE ON CALL — A group of cardiologists is taking a hard stance against renal denervation, calling for medical device manufacturers to stop selling the technology as a treatment for hypertension.

Over-stenting doc costs bosses $37M in patient complaints | On Call

April 9, 2014 by Arezu Sarvestani

Maryland-based St. Joseph Medical Center's former owner agrees to pay up to $37 million to settle allegations that a former cardiologist put as more than 270 patients through unnecessary stenting procedures. On Call

MASSDEVICE ON CALL — A years-old over-stenting dispute is coming to a head as the former owner of St. Joseph Medical Center in Maryland agreed to pay up to $37 million to resolve patient lawsuits.

I-Flow settles pain pump patent row with Progressive Medical | On Call

April 8, 2014 by Arezu Sarvestani

Pain pump maker I-Flow closes the books on a patent infringement lawsuit with distributor Progressive Medical. On Call

MASSDEVICE ON CALL — California's I-Flow finally put to bed a patent infringement lawsuit with device distributor Progressive Medical, keeping the details under wraps.

I-Flow had sued Progressive in 2012, claiming that the distributor's AccuFlo infusion pumps infringed on I-Flow's patents for an infusion device contained in a collapsible housing.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp